Skip to main content
Equibles

Eben Tessari

Kiniksa Pharmaceuticals International, plc (KNSA)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Eben Tessari

Kiniksa Pharmaceuticals International, plc reported in an 8-K filed May 1, 2026 that Eben Tessari resigned as Chief Strategy Officer, effective May 15, 2026. Kiniksa Pharmaceuticals International, plc reported in an 8-K filed January 14, 2026 that Eben Tessari was appointed Chief Strategy Officer, effective January 10, 2026. Eben Tessari has spoken on 7 earnings calls across 1 company, most recently for Kiniksa Pharmaceuticals International, plc on April 23, 2024.

“On April 30, 2026, Eben Tessari informed Kiniksa Pharmaceuticals International, plc (the “Company”) of his decision to resign as Chief Strategy Officer of the Company to pursue another executive position within the life sciences industry.”
Kiniksa Pharmaceuticals International, plc Form 8-K, filed May 1, 2026 · Read the filing
“In addition, effective January 10, 2026, the Company's Board of Directors appointed Eben Tessari to the position of Chief Strategy Officer.”
Kiniksa Pharmaceuticals International, plc Form 8-K, filed January 14, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Kiniksa Pharmaceuticals International, plc

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.